The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is expected to reach USD 9.16 billion by 2034, growing at a CAGR of 13.7%. Increasing prevalence of hematologic cancers, rising demand for precision oncology, and the integration of advanced molecular diagnostic techniques are fueling market growth. Minimal residual...

Aptamers Market Overview The global aptamers market size was valued at USD 2.3 billion in 2023 and is projected to reach USD 17.4 billion by 2032, registering a CAGR of 24.8% during the forecast period (2024-2032). Increased R&D spending and regular technological advancements are the primary drivers of Aptamer's market growth.  Download Exclusive...

Whole Exome Sequencing Market Overview The global whole exome sequencing market size was valued at USD 2.43 billion in 2024 and is anticipated to grow from USD 2.95 billion in 2025 to reach USD 14.02 billion in 2033, growing at a CAGR of 21.5% during the forecast period (2025–2033). Download Exclusive Research Report PDF Sample: (Including Full TOC,...